Artwork

Content provided by Morning Brew. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Morning Brew or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Tesla Teases Affordable Car in '25 & Why Meta AI is Everywhere

28:38
 
Share
 

Manage episode 414303509 series 2595893
Content provided by Morning Brew. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Morning Brew or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Episode 308: Neal and Toby dive into Tesla’s Q1 earnings report which certainly had its ups and downs with the announcement of a new affordable model despite having an abysmal sales performance. Then, the FTC just banned noncompete agreements because it believes it could raise the earnings of Americans. Next, Meta just released its chat bot and wants to make sure everyone knows about it. Meanwhile, there could be a new miracle drug that is a fraction of the cost of Ozempic. Also, a Finnish company wants to solve the world’s coffee supply problem with AI. Lastly, Armand Duplantis breaks his own pole vaulting record and there’s a cash incentive why.

00:00 - Intro

2:45 - Tesla’s optimistic future

7:00 - FTC bans noncompete agreements

10:30 - Meta AI is here

13:45 - Newest miracle drug for cheap?

18:00 - Cup of AI joe

21:00 - Pole vault your incentives

Get your Morning Brew Daily Merch HERE: https://shop.morningbrew.com/products/morning-brew-daily-sweatshirt?utm_medium=multimedia&utm_source=podcast&utm_campaign=mbd&utm_content=shownotes

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD

Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

627 episodes

Artwork
iconShare
 
Manage episode 414303509 series 2595893
Content provided by Morning Brew. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Morning Brew or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Episode 308: Neal and Toby dive into Tesla’s Q1 earnings report which certainly had its ups and downs with the announcement of a new affordable model despite having an abysmal sales performance. Then, the FTC just banned noncompete agreements because it believes it could raise the earnings of Americans. Next, Meta just released its chat bot and wants to make sure everyone knows about it. Meanwhile, there could be a new miracle drug that is a fraction of the cost of Ozempic. Also, a Finnish company wants to solve the world’s coffee supply problem with AI. Lastly, Armand Duplantis breaks his own pole vaulting record and there’s a cash incentive why.

00:00 - Intro

2:45 - Tesla’s optimistic future

7:00 - FTC bans noncompete agreements

10:30 - Meta AI is here

13:45 - Newest miracle drug for cheap?

18:00 - Cup of AI joe

21:00 - Pole vault your incentives

Get your Morning Brew Daily Merch HERE: https://shop.morningbrew.com/products/morning-brew-daily-sweatshirt?utm_medium=multimedia&utm_source=podcast&utm_campaign=mbd&utm_content=shownotes

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD

Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

627 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide